Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

Najibah Aliyu Galadanci, MBBS MPH, Shehu Umar Abdullahi, MBBS, Leah Danielle Vance, BS, Musa Tabari, MBBS, Shehi Abubakar, MBBS, Belonwu Raymond, MBBS, Salihu Auwal, MBBS, Aisha Amal Galadanci, MBBS, Binta WUDIL Jibir, MBBS MPH, Halima Bello-Manga, MBBS, MPH, Kathleen A Neville, MD MS, Fenella Kirkham, MD, Yu Shyr, MD, Sharon E. Phillips, MSPH, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Lori Jordan, MD, Muktar Aliyu, MD PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 122.

https://doi.org/10.1182/blood.V128.22.122.122

Published: 2016

Journal Articles

The BET Protein BRD2 Cooperates with CTCF to Enforce a Transcriptional Boundary in Erythroid Cells

Sarah C. Hsu, Caroline Bartman, Aaron J Stonestrom, MD PhD, Christopher R Edwards, PhD, Thomas Gilgenast, Daniel Emerson, Peng Huang, PhD, Michael T. Werner, Kristen Jahn, Cheryl A. Keller, PhD, Belinda Giardine, Ross C. Hardison, PhD, Arjun Raj, PhD, Jennifer E. Phillips-Cremins, PhD, Gerd A. Blobel, MD PhD

Blood (2016) 128 (22): 1034.

https://doi.org/10.1182/blood.V128.22.1034.1034

Published: 2016

Journal Articles

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Kate L E Phillips, PhD, Joanne E Dean, BSc, Brian F Flanagan, PhD, Steve E Christmas, DPhil, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2016) 128 (22): 2524.

https://doi.org/10.1182/blood.V128.22.2524.2524

Published: 2016

Journal Articles

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

John H. Chen, Daniel J. Lenihan, MD, Sharon E. Phillips, MSPH, Madan H. Jagasia, Stacey A. Goodman, MD MS, Adetola A. Kassim, MD MS, Shelton L. Lacy, Kevin T. McDonagh, Javid J. Moslehi, MD, Tarsheen K. Sethi, MD MS, David A. Slosky, Oluchi C. Ukaegbu, MD, Robert F. Cornell

Blood (2015) 126 (23): 5363.

https://doi.org/10.1182/blood.V126.23.5363.5363

Published: 2015

Journal Articles

Normal Lymphocytes at Diagnosis and during Induction Chemotherapy in Childhood Acute Lymphoblastic Leukaemia in Peripheral Blood and Bone Marrow Are Predominantly CD3+, CD4+ or CD8+, CCR7+, CD45RA+, HLA-DR-

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4982.

https://doi.org/10.1182/blood.V126.23.4982.4982

Published: 2015

Journal Articles

Application of Human Immunophenotyping Consortium Panels to Early Childhood Leukaemia; From Diagnosis to End of Induction Chemotherapy

Kate L E Phillips, PhD, Steve E Christmas, DPhil, Brian F Flanagan, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 4995.

https://doi.org/10.1182/blood.V126.23.4995.4995

Published: 2015

Journal Articles

Hydroxyurea Therapy for Sickle Cell Disorders in Childhood: Adherence to Therapy Transforms Lives and Needs to be the Focus - the Experience of Alder Hey Children's Hospital

Louise Smith, RCN MSc, Kate L E Phillips, PhD, Russell D Keenan, MB ChB, PhD FRCP, FRCPath

Blood (2015) 126 (23): 990.

https://doi.org/10.1182/blood.V126.23.990.990

Published: 2015

Journal Articles

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Ilka Decker, MD MS, Oluchi C. Ukaegbu, MD, Stacey A. Goodman, MD MS, Daniel J. Lenihan, MD, Rebecca R Hung, MD, Adetola A. Kassim, MD MS, Shelton L. Harrell, MSN, ACNP-BC, Kevin McDonagh, MD, Sharon E. Phillips, MSPH, Kyle T Rawling, Samuel M Rubinstein, MD, Tarsheen K. Sethi, MD MS, Robert F Cornell, MD MS

Blood (2015) 126 (23): 1841.

https://doi.org/10.1182/blood.V126.23.1841.1841

Published: 2015

Journal Articles

Coagulopathy Is a Strong Independent Predictor Of In-Hospital Mortality Following Massive Transfusion: Initial Results From The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Amanda J Zatta, BSc (Hons), PhD, Zoe K McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, David J Roxby, MBBS, Naomi J Aoki, BSc, MSc, Krishna Badami, MBBS, Larry McNicol, MBBS, Ken Davis, BSc (Hons), Scott Dunkley, MBBS, Catherine Hurn, MBBS, Louise E Phillips, BSc(Hons), MPH, PhD, James P Isbister, MBBS, Peter A Cameron, MBBS, PhD, Erica M Wood, MBBS

Blood (2013) 122 (21): 2402.

https://doi.org/10.1182/blood.V122.21.2402.2402

Published: 2013

Journal Articles

Introduction Of Universal Leucodepletion Associated With a Reduction In New Renal Failure, But Not Infection Or Mortality, In Cardiac Surgery Patients: Results From a Before and After Study

Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS MBiostat, Leo Van De Watering, MD PhD, Louise E. Phillips, BSc(Hons), MPH, PhD, Merrole Faye Cole-Sinclair, Christopher Reid, PhD, Peter A. Cameron, MBBS, PhD, John J. McNeil, MD, PhD, Erica M. Wood, MBBS

Blood (2013) 122 (21): 788.

https://doi.org/10.1182/blood.V122.21.788.788

Published: 2013

Journal Articles

Early and nonreversible decrease of CD161 ++ /MAIT cells in HIV infection

Blood (2013) 121 (6): 951–961.

https://doi.org/10.1182/blood-2012-06-436436

Published: 2013

Includes: Supplemental data

Journal Articles

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Mark N Polizzotto, MBBS, BMedSc, Amanda J Zatta, BSc (Hons), PhD, Merrole F Cole-Sinclair, MBBS, BSc (Hons), Erica M Wood, MBBS, Zoe K McQuilten, MBBS, Scott Dunkley, MBBS FRACP FRCPA, Peter Cameron, MBBS, PhD, Louise E Phillips, BSc (Hons), MPH, PhD

Blood (2011) 118 (21): 3311.

https://doi.org/10.1182/blood.V118.21.3311.3311

Published: 2011

Journal Articles

Ten Years and Over 3600 Cases of Recombinant Activated Factor VII Use: What Does the Haemostasis Registry Data Tell Us?

Louise E Phillips, BSc, (hons), MPH, PhD, Amanda J Zatta, BSc, (Hons), PhD, James Isbister, MD, Scott Dunkley, MD, John McNeil, MD, PhD, Peter Cameron, MD, PhD

Blood (2010) 116 (21): 3352.

https://doi.org/10.1182/blood.V116.21.3352.3352

Published: 2010

Journal Articles

Transfusion Association with Adverse Clinical Outcomes in Cardiac Surgery: An Analysis of a Large Patient Cohort.

Zoe K McQuilten, MBBS, Mark N Polizzotto, BMedSc, MBBS, Erica M Wood, FRACP, FRCPA, Merrole F Cole-Sinclair, MBBS, Chris Reid, Louise E Phillips, PhD, BSc, (Hons)

Blood (2009) 114 (22): 3158.

https://doi.org/10.1182/blood.V114.22.3158.3158

Published: 2009

Journal Articles

Adherence to Transfusion Protocols and the Use of Recombinant Activated Factor VII.

Louise E Phillips, BSc, (Hons), PhD, Cameron Willis, PhD, Amanda Zatta, PhD, Scott Dunkley, BMed(hons), FRACP, FRCPA, Peter Cameron, MD, MBBS, FACEM, Hatem H. Salem, MD, FRACP, FRCPA, James Isbister, MB, BS, BSc(MED), FRACP, FRCPA

Blood (2009) 114 (22): 4192.

https://doi.org/10.1182/blood.V114.22.4192.4192

Published: 2009

Journal Articles

The Use of Recombinant Activated Factor VII in Australia and New Zealand.

Scott Dunkley, Peter A. Cameron, MBBS FACEM MD, Louise E. Phillips, BSc (Hons) PhD, James Isbister

Blood (2006) 108 (11): 4025.

https://doi.org/10.1182/blood.V108.11.4025.4025

Published: 2006

Journal Articles

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)

S Kempin, BJ 3d Lee, HT Thaler, B Koziner, S Hecht, T Gee, Z Arlin, C Little, D Straus, L Reich, E Phillips, H Al-Mondhiry, M Dowling, K Mayer, B Clarkson

Blood (1982) 60 (5): 1110–1121.

https://doi.org/10.1182/blood.V60.5.1110.1110

Published: 1982

Journal Articles

Guanidinosuccinic Acid on Human Platelet Effects of Exogenous Urea, Creatinine, and Aggregation In Vitro

James W. Davis, M.D., James R. McField, B.S., Phyllis E. Phillips, Barbara A. Graham, B.S.

Blood (1972) 39 (3): 388–397.

https://doi.org/10.1182/blood.V39.3.388.388

Published: 1972

Journal Articles

The Effect of Imidazole on Human Platelet Aggregation

JAMES W. DAVIS, M.D., PHYLLIS E. PHILLIPS

Blood (1971) 38 (4): 417–421.

https://doi.org/10.1182/blood.V38.4.417.417

Published: 1971

NARROW

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

The BET Protein BRD2 Cooperates with CTCF to Enforce a Transcriptional Boundary in Erythroid Cells

Potential for Dendritic Cell Stimulated De Novo Anti-Leukaemia CD4 T Cell Response in the Bone Marrow Tumour Microenvironment during Induction Chemotherapy

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

Normal Lymphocytes at Diagnosis and during Induction Chemotherapy in Childhood Acute Lymphoblastic Leukaemia in Peripheral Blood and Bone Marrow Are Predominantly CD3+, CD4+ or CD8+, CCR7+, CD45RA+, HLA-DR-

Application of Human Immunophenotyping Consortium Panels to Early Childhood Leukaemia; From Diagnosis to End of Induction Chemotherapy

Hydroxyurea Therapy for Sickle Cell Disorders in Childhood: Adherence to Therapy Transforms Lives and Needs to be the Focus - the Experience of Alder Hey Children's Hospital

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Coagulopathy Is a Strong Independent Predictor Of In-Hospital Mortality Following Massive Transfusion: Initial Results From The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Introduction Of Universal Leucodepletion Associated With a Reduction In New Renal Failure, But Not Infection Or Mortality, In Cardiac Surgery Patients: Results From a Before and After Study

Early and nonreversible decrease of CD161 ++ /MAIT cells in HIV infection

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Ten Years and Over 3600 Cases of Recombinant Activated Factor VII Use: What Does the Haemostasis Registry Data Tell Us?

Transfusion Association with Adverse Clinical Outcomes in Cardiac Surgery: An Analysis of a Large Patient Cohort.

Adherence to Transfusion Protocols and the Use of Recombinant Activated Factor VII.

The Use of Recombinant Activated Factor VII in Australia and New Zealand.

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)

Guanidinosuccinic Acid on Human Platelet Effects of Exogenous Urea, Creatinine, and Aggregation In Vitro

The Effect of Imidazole on Human Platelet Aggregation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only